• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA 框架核酸对蛛网膜下腔出血后弥漫性微血管内皮细胞损伤的治疗作用。

Treatment effect of DNA framework nucleic acids on diffuse microvascular endothelial cell injury after subarachnoid hemorrhage.

机构信息

Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.

Department of Gynecological Nursing, West China Second University Hospital, West China School of Nursing, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Ministry of Education), Sichuan University, Chengdu, China.

出版信息

Cell Prolif. 2022 Apr;55(4):e13206. doi: 10.1111/cpr.13206. Epub 2022 Feb 21.

DOI:10.1111/cpr.13206
PMID:35187748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9055902/
Abstract

OBJECTIVES

The purpose of this study was to investigate the treatment effect and molecular mechanism of tetrahedral framework nucleic acids (tFNAs), novel self-assembled nucleic acid nanomaterials, in diffuse BMEC injury after SAH.

MATERIALS AND METHODS

tFNAs were synthesized from four ssDNAs. The effects of tFNAs on SAH-induced diffuse BMEC injury were explored by a cytotoxicity model induced by hemin, a breakdown product of hemoglobin, in vitro and a mouse model of SAH via internal carotid artery puncture in vivo. Cell viability assays, wound healing assays, transwell assays, and tube formation assays were performed to explore cellular function like angiogenesis.

RESULTS

In vitro cellular function assays demonstrated that tFNAs could alleviate hemin-induced injury, promote angiogenesis, and inhibit apoptosis in hemin cytotoxicity model. In vivo study using H&E and TEM results jointly indicated that the tFNAs attenuate the damage caused by SAH in situ, showing restored number of BMECs in the endothelium layer and more tight intercellular connectivity. Histological examination of SAH model animals confirmed the results of the in vitro study, as tFNAs exhibited treatment effects against diffuse BMEC injury in the cerebral microvascular bed.

CONCLUSIONS

Our study suggests the potential of tFNAs in ameliorating diffuse injury to BMECs after SAH, which laid theoretical foundation for the further study and use of these nucleic acid nanomaterials for tissue engineering vascularization.

摘要

目的

本研究旨在探讨四面体框架核酸(tFNAs)——一种新型自组装核酸纳米材料——在蛛网膜下腔出血(SAH)后弥漫性 BMEC 损伤中的治疗效果和分子机制。

材料和方法

tFNAs 由四条 ssDNA 合成。通过体外血红素(血红蛋白的降解产物)诱导的细胞毒性模型和体内通过颈内动脉穿刺的 SAH 小鼠模型,研究 tFNAs 对 SAH 诱导的弥漫性 BMEC 损伤的影响。进行细胞活力测定、划痕愈合测定、Transwell 测定和管形成测定,以探索血管生成等细胞功能。

结果

体外细胞功能测定表明,tFNAs 可减轻血红素诱导的损伤,促进血红素细胞毒性模型中的血管生成和抑制细胞凋亡。使用 H&E 和 TEM 结果的体内研究共同表明,tFNAs 可减轻原位 SAH 引起的损伤,表现为内皮细胞层中 BMEC 数量的恢复和细胞间连接的更加紧密。对 SAH 模型动物的组织学检查证实了体外研究的结果,因为 tFNAs 对脑微血管床中的弥漫性 BMEC 损伤表现出治疗作用。

结论

本研究表明 tFNAs 具有改善 SAH 后 BMEC 弥漫性损伤的潜力,为进一步研究和使用这些核酸纳米材料进行组织工程血管化奠定了理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b0/9055902/b81627b71b02/CPR-55-e13206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b0/9055902/3af0218bef4b/CPR-55-e13206-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b0/9055902/009731f5e29d/CPR-55-e13206-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b0/9055902/0fd632b4a469/CPR-55-e13206-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b0/9055902/4555a616a6cc/CPR-55-e13206-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b0/9055902/b81627b71b02/CPR-55-e13206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b0/9055902/3af0218bef4b/CPR-55-e13206-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b0/9055902/009731f5e29d/CPR-55-e13206-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b0/9055902/0fd632b4a469/CPR-55-e13206-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b0/9055902/4555a616a6cc/CPR-55-e13206-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b0/9055902/b81627b71b02/CPR-55-e13206-g001.jpg

相似文献

1
Treatment effect of DNA framework nucleic acids on diffuse microvascular endothelial cell injury after subarachnoid hemorrhage.DNA 框架核酸对蛛网膜下腔出血后弥漫性微血管内皮细胞损伤的治疗作用。
Cell Prolif. 2022 Apr;55(4):e13206. doi: 10.1111/cpr.13206. Epub 2022 Feb 21.
2
Tetrahedral framework nucleic acids inhibit pathological neovascularization and vaso-obliteration in ischaemic retinopathy via PI3K/AKT/mTOR signalling pathway.四面体框架核酸通过 PI3K/AKT/mTOR 信号通路抑制缺血性视网膜病变中的病理性新生血管形成和血管闭塞。
Cell Prolif. 2023 Jul;56(7):e13407. doi: 10.1111/cpr.13407. Epub 2023 Jan 24.
3
Antioxidative and Angiogenesis-Promoting Effects of Tetrahedral Framework Nucleic Acids in Diabetic Wound Healing with Activation of the Akt/Nrf2/HO-1 Pathway.四面体核酸通过激活 Akt/Nrf2/HO-1 通路在糖尿病创面愈合中的抗氧化和促进血管生成作用。
ACS Appl Mater Interfaces. 2020 Mar 11;12(10):11397-11408. doi: 10.1021/acsami.0c00874. Epub 2020 Feb 28.
4
Tetrahedral framework nucleic acids promote diabetic wound healing via the Wnt signalling pathway.四面体型核酸通过 Wnt 信号通路促进糖尿病创面愈合。
Cell Prolif. 2022 Nov;55(11):e13316. doi: 10.1111/cpr.13316. Epub 2022 Jul 22.
5
Tetrahedral Framework Nucleic Acids Connected with MicroRNA-126 Mimics for Applications in Vascular Inflammation, Remodeling, and Homeostasis.四面体框架核酸与 miRNA-126 模拟物的连接及其在血管炎症、重塑和动态平衡中的应用。
ACS Appl Mater Interfaces. 2022 May 4;14(17):19091-19103. doi: 10.1021/acsami.1c23869. Epub 2022 Apr 13.
6
Tetrahedral framework nucleic acids for improving wound healing.四面体框架核酸在促进伤口愈合中的应用。
J Nanobiotechnology. 2024 Mar 16;22(1):113. doi: 10.1186/s12951-024-02365-z.
7
Tetrahedral Framework Nucleic Acids Promote Corneal Epithelial Wound Healing in Vitro and in Vivo.四面体框架核酸促进体外和体内角膜上皮伤口愈合。
Small. 2019 Aug;15(31):e1901907. doi: 10.1002/smll.201901907. Epub 2019 Jun 13.
8
Tetrahedral Framework Nucleic Acids Promote Senile Osteoporotic Fracture Repair by Enhancing Osteogenesis and Angiogenesis of Callus.四面体框架核酸通过增强骨痂的成骨和血管生成促进老年骨质疏松性骨折修复。
ACS Appl Mater Interfaces. 2023 May 31;15(21):25403-25416. doi: 10.1021/acsami.3c03569. Epub 2023 May 18.
9
Tetrahedral Framework Nucleic Acids Inhibit Skin Fibrosis via the Pyroptosis Pathway.四面体框架核酸通过细胞焦亡途径抑制皮肤纤维化。
ACS Appl Mater Interfaces. 2022 Apr 6;14(13):15069-15079. doi: 10.1021/acsami.2c02877. Epub 2022 Mar 23.
10
Tetrahedral framework nucleic acids alleviate irradiation-induced salivary gland damage.四面体框架核酸可减轻辐射诱导的唾液腺损伤。
Cell Prolif. 2023 Apr;56(4):e13381. doi: 10.1111/cpr.13381. Epub 2022 Dec 13.

引用本文的文献

1
Current Understanding and Translational Prospects of Tetrahedral Framework Nucleic Acids.四面体骨架核酸的当前理解与转化前景
JACS Au. 2025 Feb 10;5(2):486-520. doi: 10.1021/jacsau.4c01170. eCollection 2025 Feb 24.
2
Single-Cell Transcriptomics Revealed White Matter Repair Following Subarachnoid Hemorrhage.单细胞转录组学揭示蛛网膜下腔出血后的白质修复
Transl Stroke Res. 2025 Jun;16(3):800-816. doi: 10.1007/s12975-024-01265-6. Epub 2024 Jun 11.
3
Tetrahedral framework nucleic acids for improving wound healing.四面体框架核酸在促进伤口愈合中的应用。

本文引用的文献

1
YQFM alleviated cardiac hypertrophy by apoptosis inhibition and autophagy regulation via PIK/AKT/mTOR pathway.YQFM 通过 PIK/AKT/mTOR 通路抑制细胞凋亡和自噬调节减轻心肌肥厚。
J Ethnopharmacol. 2022 Mar 1;285:114835. doi: 10.1016/j.jep.2021.114835. Epub 2021 Nov 16.
2
Functionalizing Framework Nucleic-Acid-Based Nanostructures for Biomedical Application.功能化基于框架核酸的纳米结构用于生物医学应用。
Adv Mater. 2022 Nov;34(46):e2107820. doi: 10.1002/adma.202107820. Epub 2022 Feb 20.
3
The biological applications of DNA nanomaterials: current challenges and future directions.
J Nanobiotechnology. 2024 Mar 16;22(1):113. doi: 10.1186/s12951-024-02365-z.
4
Biomimetic fabrication of sr-silk fibroin co-assembly hydroxyapatite based microspheres with angiogenic and osteogenic properties for bone tissue engineering.用于骨组织工程的具有血管生成和成骨特性的锶-丝素蛋白共组装羟基磷灰石基微球的仿生制备
Mater Today Bio. 2024 Feb 27;25:101011. doi: 10.1016/j.mtbio.2024.101011. eCollection 2024 Apr.
5
Tetrahedral framework nucleic acids-based delivery of MicroRNA-22 inhibits pathological neovascularization and vaso-obliteration by regulating the Wnt pathway.基于四面体型核酸框架的 MicroRNA-22 递呈通过调控 Wnt 通路抑制病理性新生血管形成和血管闭塞。
Cell Prolif. 2024 Jul;57(7):e13623. doi: 10.1111/cpr.13623. Epub 2024 Mar 3.
6
Modulation of Cerebrospinal Fluid Dysregulation via a SPAK and OSR1 Targeted Framework Nucleic Acid in Hydrocephalus.通过针对脑积水的 SPAK 和 OSR1 的靶向框架核酸调节脑脊液失调。
Adv Sci (Weinh). 2024 May;11(17):e2306622. doi: 10.1002/advs.202306622. Epub 2024 Feb 14.
7
DNA framework signal amplification platform-based high-throughput systemic immune monitoring.基于 DNA 框架信号放大平台的高通量系统免疫监测。
Signal Transduct Target Ther. 2024 Feb 7;9(1):28. doi: 10.1038/s41392-024-01736-0.
8
A DNA nanostructure-Hif-1α inducer complex as novel nanotherapy against cisplatin-induced acute kidney injury.一种 DNA 纳米结构-Hif-1α 诱导物复合物,作为一种新型纳米疗法,用于治疗顺铂诱导的急性肾损伤。
Cell Prolif. 2024 Jun;57(6):e13601. doi: 10.1111/cpr.13601. Epub 2024 Jan 14.
9
Influencing Endothelial Cells' Roles in Inflammation and Wound Healing Through Nucleic Acid Delivery.通过核酸递送来影响内皮细胞在炎症和创伤愈合中的作用。
Tissue Eng Part A. 2024 Apr;30(7-8):272-286. doi: 10.1089/ten.TEA.2023.0296. Epub 2024 Feb 7.
10
A Novel Bioswitchable miRNA Mimic Delivery System: Therapeutic Strategies Upgraded from Tetrahedral Framework Nucleic Acid System for Fibrotic Disease Treatment and Pyroptosis Pathway Inhibition.一种新型的双稳态 miRNA 模拟物递药系统:基于四面体核酸系统的纤维化疾病治疗和细胞焦亡通路抑制的治疗策略升级。
Adv Sci (Weinh). 2024 Jan;11(1):e2305622. doi: 10.1002/advs.202305622. Epub 2023 Nov 20.
DNA 纳米材料的生物学应用:当前的挑战和未来的方向。
Signal Transduct Target Ther. 2021 Oct 8;6(1):351. doi: 10.1038/s41392-021-00727-9.
4
Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis.下一代营养基因组癌症治疗的多模态方法:萝卜硫素与乙酰唑胺联合使用可通过抑制PI3K/Akt/mTOR生存途径并诱导细胞凋亡来有效靶向支气管类癌。
Oncotarget. 2021 Jul 20;12(15):1470-1489. doi: 10.18632/oncotarget.28011.
5
Claudin-1/4 as directly target gene of HIF-1α can feedback regulating HIF-1α by PI3K-AKT-mTOR and impact the proliferation of esophageal squamous cell though Rho GTPase and p-JNK pathway.Claudin-1/4 作为 HIF-1α 的直接靶基因,可以通过 PI3K-AKT-mTOR 途径反馈调节 HIF-1α,通过 Rho GTPase 和 p-JNK 途径影响食管鳞状细胞的增殖。
Cancer Gene Ther. 2022 Jun;29(6):665-682. doi: 10.1038/s41417-021-00328-2. Epub 2021 Jul 19.
6
Possible Mechanism of Human Recombinant Leptin-Induced VEGF A Synthesis via PI3K/Akt/mTOR/S6 Kinase Signaling Pathway while Inducing Angiogenesis: An Analysis Using Chicken Chorioallantoic Membrane Model.人重组瘦素诱导血管内皮生长因子 A 合成的可能机制通过 PI3K/Akt/mTOR/S6 激酶信号通路诱导血管生成:鸡胚尿囊膜模型分析。
J Vasc Res. 2021;58(6):343-360. doi: 10.1159/000516498. Epub 2021 Jun 24.
7
BCAT1 Activates PI3K/AKT/mTOR Pathway and Contributes to the Angiogenesis and Tumorigenicity of Gastric Cancer.BCAT1激活PI3K/AKT/mTOR通路并促进胃癌的血管生成和致瘤性。
Front Cell Dev Biol. 2021 Jun 7;9:659260. doi: 10.3389/fcell.2021.659260. eCollection 2021.
8
Fluid metabolic pathways after subarachnoid hemorrhage.蛛网膜下腔出血后的液体代谢途径。
J Neurochem. 2022 Jan;160(1):13-33. doi: 10.1111/jnc.15458. Epub 2021 Jul 12.
9
Tetrahedral Framework Nucleic Acids Induce Immune Tolerance and Prevent the Onset of Type 1 Diabetes.四面体框架核酸诱导免疫耐受并预防 1 型糖尿病的发生。
Nano Lett. 2021 May 26;21(10):4437-4446. doi: 10.1021/acs.nanolett.1c01131. Epub 2021 May 6.
10
Liraglutide Protects Nucleus Pulposus Cells Against High-Glucose Induced Apoptosis by Activating PI3K/Akt/ mTOR/Caspase-3 and PI3K/Akt/GSK3β/Caspase-3 Signaling Pathways.利拉鲁肽通过激活PI3K/Akt/mTOR/Caspase-3和PI3K/Akt/GSK3β/Caspase-3信号通路保护髓核细胞免受高糖诱导的凋亡。
Front Med (Lausanne). 2021 Feb 19;8:630962. doi: 10.3389/fmed.2021.630962. eCollection 2021.